Vaccines for Enteric Diseases

16-18 October 2019, CHUV, University of Lausanne, Lausanne, Switzerland

  • Increase font size
  • Default font size
  • Decrease font size

Day Three

Final Conference Programme | Friday 18th October 2019

SESSION 9:
CHOLERA

Moderators: David Sack (Johns Hopkins University, Baltimore, Maryland, USA)

09.00-09.30
‘Contrasting cholera epidemiology between Africa and Asia: Implications for vaccination strategies’

David Sack
(Johns Hopkins University, Baltimore, Maryland, USA)

09.30-10.00
’Hillchol-B: A novel dry-formulation, heat-stable, low-cost enterocoated single-strain+B-subunit oral cholera vaccine’

J. Holmgren, M. Lebens, M. Löfstrand, S. Nordqvist, M. Terrinoni, T. Sharma, K. Ali and D. Gill
(University of Gothenberg, Gothenberg, Sweden; Hilleman Research Laboratories, New Delhi, India)

10.00-10.20
‘Effect of extended dose intervals on immune response to oral cholera vaccine in Zambia’

John Mwaba1*, Caroline Cleopatra Chisenga1, Patrick Shea2, Chileshe Mabula-Bwalya1, Katayi Mwila-Kazimbaya1, Natasha Makabilo Laban1, Masuzyo Chirwa-Chobe1, Mohammad Ali, Michelo Simuyandi1, David A. Sack2, Roma Chilengi1 and Amanda Debes2
(1 Research Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia; 2 Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA)

10.20-10.40
Vibrio cholerae transmission in Bangladesh: Insights from a national serosurvey’

Andrew S. Azman1, Justin Lessler1, Daniel Leung3, Francisco J. Luquero2, Jason Harris4, Stephen Lauer1, Fatema Khaton5, Jannatul Ferdous5, Kishor Kumar Paul5, Taufiqur Bhuiyan5, Henrik Salje6,1, Firdausi Qadri5 and Emily S. Gurley1
(1 Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; 2 Epicentre, Geneva, Switzerland; 3 University of Utah School of Medicine, Salt Lake City, Utah, USA; 4 Massachusetts General Hospital, Boston, Massachusetts, USA; 5 icddr,b (International Center for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh; 6 Institut Pasteur, Paris, France)

10.40-11.00
‘The association between Helicobacter pylori infection and the immune response to CVD 103-HgR live oral cholera vaccine’
Khitam Muhsen1, Samba O. Sow2,3, Milagritos D. Tapia2,3, Mardi Reymann3, Marcela F. Pasetti3 and Myron M. Levine3
(1 Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 2 Centre pour le Développement des Vaccins, Bamako, Mali; 3 Center for Vaccine Development and Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA)

11.00-11.20
Coffee Break & Posters Breakdown

SESSION 10:
ROTAVIRUS VACCINES

Moderators: K. Zaman (icddr,b (International Center for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh) and Bernd Benninghoff (GSK, Wavre, Belgium)

11.20-11.50
‘Rotavirus vaccine: From development to global use’
K. Zaman
(icddr,b (International Center for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh)

11.50-12.20
‘Success story of human rotavirus vaccine: Lessons learned’
Bernd Benninghoff
(GSK, Wavre, Belgium)

12.20-13.00
Lunch Break & Posters

SESSION 10 CONTINUED

13.00-13.20
‘Evidence of genotype independent protection against rotavirus disease in long term follow up of rotavirus vaccination’
Maria Hemming-Harlo, Jukka Markkula and Timo Vesikari
(Tampere University, Tampere, Finland)

13.20-13.40
‘Rotavirus vaccine effectiveness against all-cause diarrhea and antimicrobial consumption in low- and middle-income countries: A case-control analysis and vaccine probe study’
Joseph A. Lewnard1*, Nathan C. Lo2,3, Nimalan Arinaminpathy4, Isabel Frost5 and Ramanan Laxminarayan5,6
(1 Division of Epidemiology, University of California, Berkeley School of Public Health, Berkeley, California, USA; 2 Division of Epidemiology, Stanford University School of Medicine, Stanford, California, USA; 3 Department of Medicine, University of California, San Francisco, San Francisco, California, USA; 4 School of Public Health, Imperial College, London, London, UK; 5 Center for Disease Dynamics, Economics & Policy, New Delhi, India; 6 Princeton Environmental Institute, Princeton University, Princeton, New Jersey)

13.40-14.00
‘The effects of increased inoculum on oral rotavirus vaccine take and immunogenicity among infants in Dhaka, Bangladesh’
Benjamin Lee1, Dorothy Dickson1, Masud Alum2, Sajia Afreen2, Abdul Kader2, Faria Afrin2, Tania Ferdousi2, Christina Damon1, Soyeon Kim1, Monica McNeal3, Daniel Bak1, Mona Tolba1, Marya Carmolli1, Mami Taniuchi4, Rashidul Haque2 and Beth D. Kirkpatrick1
(1 University of Vermont; Burlington, Vermont, USA; 2 icddr,b (International Center for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh; 3 Cincinnati Children’s Hospital Medical Center; Cincinnati, Ohio, USA; 4 University of Virginia, Charlottesville, Virginia, USA)

14.00-14.20
‘Maternal secretor status affects oral rotavirus vaccine response in breastfed infants in Bangladesh’
Frank B. Williams1, Abdul Kader2, Dorothy M. Dickson1, E. Ross Colgate1, Muhammad Ikhtear Uddin2, Salma Sharmin2, Shahidul Islam2, Taufiqur Rahman Bhuiyan2, Masud Alam2, Uma Nayak3, Josyf C. Mychaleckyj3, William A. Petri, Jr.3, Rashidul Haque2, Firdausi Qadri2, Beth D. Kirkpatrick1 and Benjamin Lee1
(1 University of Vermont; Burlington, Vermont, USA; 2 International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh; 3 University of Virginia; Charlottesville, Virginia, USA)

14.20
Closing Remarks & Departure

* This final programme is correct at the time of publication. However the organizers reserve the right to make any alterations that may be required in the interests and integrity of the conference programme.

 

VED 2019 Delegates

Login details will be supplied after you have registered for the event.


VED 2019 Sponsors

  • Vismederi
  • Scandinavian Biopharma
  • hVIVO
  • Sanofi Pasteur
  • Takeda
  • NatureGeneTherapy.com
  • Aldevron
  • PATH
  • Vaxart
  • BioVAXX
  • Eveliqure
  • Vaccine Research Center
  • DNAvaccine.com
  • LimmaTech Biologics
  • Matrivax

VED 2019 Downloads

VED 2019 Leaflet

VED 2019 Mailing List

Name
E-mail Address
What is 3+2-1?